Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

PDL BioPharma Current Ratio 2006-2019 | PDLI

PDL BioPharma current ratio from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
  
PDL BioPharma Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-06-30 $0.40B $0.04B 10.43
2019-03-31 $0.48B $0.04B 11.02
2018-12-31 $0.52B $0.05B 9.86
2018-09-30 $0.51B $0.05B 10.88
2018-06-30 $0.51B $0.05B 11.13
2018-03-31 $0.51B $0.05B 10.03
2017-12-31 $0.64B $0.19B 3.32
2017-09-30 $0.61B $0.19B 3.16
2017-06-30 $0.54B $0.28B 1.94
2017-03-31 $0.54B $0.28B 1.98
2016-12-31 $0.40B $0.13B 3.05
2016-09-30 $0.36B $0.12B 2.92
2016-06-30 $0.32B $0.02B 14.19
2016-03-31 $0.38B $0.03B 13.04
2015-12-31 $0.28B $0.04B 7.70
2015-09-30 $0.31B $0.10B 3.24
2015-06-30 $0.37B $0.14B 2.55
2015-03-31 $0.50B $0.34B 1.46
2014-12-31 $0.36B $0.19B 1.89
2014-09-30 $0.34B $0.26B 1.31
2014-06-30 $0.23B $0.31B 0.75
2014-03-31 $0.36B $0.35B 1.03
2013-12-31 $0.11B $0.41B 0.26
2013-09-30 $0.33B $0.21B 1.59
2013-06-30 $0.28B $0.24B 1.20
2013-03-31 $0.26B $0.07B 3.76
2012-12-31 $0.18B $0.01B 17.47
2012-09-30 $0.20B $0.03B 6.28
2012-06-30 $0.24B $0.09B 2.56
2012-03-31 $0.21B $0.15B 1.38
2011-12-31 $0.23B $0.13B 1.76
2011-09-30 $0.22B $0.17B 1.26
2011-06-30 $0.21B $0.22B 0.98
2011-03-31 $0.19B $0.35B 0.53
2010-12-31 $0.29B $0.19B 1.47
2010-09-30 $0.24B $0.21B 1.13
2010-06-30 $0.24B $0.31B 0.78
2010-03-31 $0.33B $0.42B 0.80
2009-12-31 $0.32B $0.29B 1.08
2009-09-30 $0.25B $0.27B 0.94
2009-06-30 $0.21B $0.07B 3.07
2009-03-31 $0.21B $0.13B 1.61
2008-12-31 $0.18B $0.03B 5.73
2008-09-30 $0.57B $0.07B 8.34
2008-06-30 $0.50B $0.06B 7.86
2008-03-31 $0.96B $0.08B 12.12
2007-12-31 $0.72B $0.12B 5.90
2007-09-30 $0.44B $0.09B 4.95
2007-06-30 $0.42B $0.10B 4.15
2007-03-31 $0.37B $0.08B 4.42
2006-12-31 $0.38B $0.11B 3.58
2006-09-30 $0.44B $0.10B 4.37
2006-06-30 $0.46B $0.07B 6.36
2006-03-31 $0.40B $0.07B 5.87
2005-12-31 $0.38B $0.07B 5.27
2005-09-30 $0.39B $0.12B 3.32
2005-06-30 $0.23B $0.07B 3.35
2005-03-31 $0.22B $0.07B 3.10
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.294B $0.198B
Protein Design Labs Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a leader in the development of humanized antibodies, PDL has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $121.841B 13.88
Gilead Sciences (GILD) United States $80.344B 9.87
Celgene (CELG) United States $67.515B 10.44
Vertex Pharmaceuticals (VRTX) United States $47.223B 51.03
Biogen (BIIB) United States $42.659B 7.58
Illumina (ILMN) United States $41.844B 49.16
CSL (CSLLY) Australia $35.681B 0.00
Regeneron Pharmaceuticals (REGN) United States $32.513B 14.76
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.986B 13.17
Incyte (INCY) United States $18.087B 53.23
Exact Sciences (EXAS) United States $15.468B 0.00
SINO PHARMACEUT (SBMFF) China $15.039B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.731B 0.00
Seattle Genetics (SGEN) United States $12.716B 0.00
Genmab (GNMSF) Denmark $12.462B 63.35
Bio-Rad Laboratories (BIO.B) United States $9.886B 52.99
Guardant Health (GH) United States $9.507B 0.00
Alnylam Pharmaceuticals (ALNY) United States $9.135B 0.00
Galapagos (GLPG) Belgium $8.548B 0.00
QIAGEN (QGEN) Netherlands $7.706B 25.31
Sarepta Therapeutics (SRPT) United States $7.588B 0.00
Bio-Techne Corp (TECH) United States $7.294B 50.42
BeiGene (BGNE) Cayman Islands $6.892B 0.00
Bluebird Bio (BLUE) United States $6.718B 0.00
Exelixis (EXEL) United States $6.591B 17.13
Amarin (AMRN) Ireland $5.512B 0.00
Horizon Pharma Public (HZNP) Ireland $5.144B 13.08
Ascendis Pharma (ASND) Denmark $4.867B 0.00
Repligen (RGEN) United States $4.749B 92.15
Moderna (MRNA) United States $4.672B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.412B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.231B 0.00
MorphoSys AG (MOR) Germany $3.897B 0.00
China Biologic Products (CBPO) China $3.897B 24.32
Spark Therapeutics (ONCE) United States $3.881B 0.00
Blueprint Medicines (BPMC) United States $3.859B 0.00
Mirati Therapeutics (MRTX) United States $3.479B 0.00
Alkermes (ALKS) Ireland $3.421B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.343B 0.00
Arena Pharmaceuticals (ARNA) United States $2.838B 6.10
Genomic Health (GHDX) United States $2.754B 51.65
Immunomedics (IMMU) United States $2.695B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.652B 0.00
NeoGenomics (NEO) United States $2.646B 141.56
Amicus Therapeutics (FOLD) United States $2.615B 0.00
Medicines (MDCO) United States $2.605B 0.00
MyoKardia (MYOK) United States $2.547B 0.00
Acceleron Pharma (XLRN) United States $2.411B 0.00
Halozyme Therapeutics (HALO) United States $2.410B 0.00
Reata Pharmaceuticals (RETA) United States $2.321B 0.00
Emergent Biosolutions (EBS) United States $2.214B 33.26
Intercept Pharmaceuticals (ICPT) United States $2.153B 0.00
UniQure (QURE) Netherlands $2.134B 0.00
Akcea Therapeutics (AKCA) United States $2.073B 0.00
Cambrex (CBM) United States $1.991B 25.17
Zai Lab (ZLAB) China $1.976B 0.00
Ligand Pharmaceuticals (LGND) United States $1.820B 23.01
Myriad Genetics (MYGN) United States $1.809B 18.98
Denali Therapeutics (DNLI) United States $1.804B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.636B 0.00
Insmed (INSM) United States $1.496B 0.00
Coherus BioSciences (CHRS) United States $1.400B 0.00
RA PHARMCTL INC (RARX) United States $1.375B 0.00
REGENXBIO (RGNX) United States $1.336B 0.00
Sangamo Therapeutics (SGMO) United States $1.331B 0.00
Editas Medicine (EDIT) United States $1.267B 0.00
Fate Therapeutics (FATE) United States $1.231B 0.00
Epizyme (EPZM) United States $1.230B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.228B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.210B 0.00
Athenex (ATNX) United States $1.205B 0.00
Innoviva (INVA) United States $1.165B 3.36
AnaptysBio (ANAB) United States $1.141B 0.00
Alector (ALEC) United States $1.101B 0.00
Zymeworks (ZYME) Canada $1.025B 0.00
Twist Bioscience (TWST) United States $1.000B 0.00
Cara Therapeutics (CARA) United States $0.943B 0.00
Principia Biopharma (PRNB) United States $0.930B 485.13
Dicerna Pharmaceuticals (DRNA) United States $0.911B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.853B 0.00
Intellia Therapeutics (NTLA) United States $0.828B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.821B 0.00
ANI Pharmaceuticals (ANIP) United States $0.815B 13.61
Arvinas (ARVN) United States $0.809B 0.00
Cytokineticsorporated (CYTK) United States $0.809B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.806B 29.08
Alder BioPharmaceuticals (ALDR) United States $0.781B 0.00
Anika Therapeutics (ANIK) United States $0.767B 27.16
Codexis (CDXS) United States $0.759B 0.00
Pharming Group (PHGUF) Netherlands $0.759B 0.00
Vericel (VCEL) United States $0.748B 0.00
Adverum Biotechnologies (ADVM) United States $0.748B 0.00
Retrophin (RTRX) United States $0.734B 0.00
WAVE Life Sciences (WVE) Singapore $0.730B 0.00
Zealand Pharma (ZEAL) Denmark $0.671B 7.79
Zealand Pharma (ZLDPF) Denmark $0.664B 0.00
Stemline Therapeutics (STML) United States $0.660B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.643B 0.00
MiMedx (MDXG) United States $0.608B 0.00
Heska (HSKA) United States $0.578B 74.92
DBV Technologies S.A (DBVT) France $0.564B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.517B 0.00
Cellectis S.A (CLLS) France $0.517B 0.00
Precision BioSciences (DTIL) United States $0.500B 0.00
Intra-Cellular Therapies (ITCI) United States $0.494B 0.00
Revance Therapeutics (RVNC) United States $0.493B 0.00
PHARMA MAR SA (PHMMF) Spain $0.479B 0.00
Syros Pharmaceuticals (SYRS) United States $0.466B 0.00
Mesoblast (MESO) Australia $0.464B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
UROGEN PHARMA (URGN) United States $0.446B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.434B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.432B 0.00
CytomX Therapeutics (CTMX) United States $0.420B 0.00
Puma Biotechnology (PBYI) United States $0.419B 0.00
Merus (MRUS) Netherlands $0.412B 0.00
BioDelivery Sciences (BDSI) United States $0.396B 0.00
Agenus (AGEN) United States $0.393B 0.00
AC Immune SA (ACIU) Switzerland $0.382B 28.25
Avid Bioservices (CDMO) United States $0.371B 0.00
Gritstone Oncology (GRTS) United States $0.368B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.364B 0.00
Kadmon Holdings (KDMN) United States $0.344B 0.00
Scholar Rock Holding (SRRK) United States $0.334B 0.00
Clovis Oncology (CLVS) United States $0.330B 0.00
Arcus Biosciences (RCUS) United States $0.326B 0.00
Biofrontera AG (BFRA) Germany $0.323B 0.00
Albireo Pharma (ALBO) United States $0.322B 0.00
Starpharma Holdings (SPHRY) Australia $0.318B 0.00
Theratechnologies (THERF) Canada $0.318B 0.00
Protagonist Therapeutics (PTGX) United States $0.309B 0.00
Prothena (PRTA) Ireland $0.307B 0.00
Cel-Sci (CVM) United States $0.299B 0.00
Sorrento Therapeutics (SRNE) United States $0.299B 0.00
Kindred Biosciences (KIN) United States $0.288B 0.00
Dynavax Technologies (DVAX) United States $0.285B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.275B 0.00
Geron (GERN) United States $0.260B 0.00
Senesco Technologies (ELOX) United States $0.253B 0.00
ADMA Biologics Inc (ADMA) United States $0.241B 0.00
PHASEBIO PHARMA (PHAS) United States $0.241B 0.00
Seres Therapeutics (MCRB) United States $0.239B 0.00
Inovio Pharmaceuticals (INO) United States $0.238B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.237B 0.00
Cellular Biomedicine (CBMG) United States $0.236B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.233B 0.00
Prometic Life Sciences (PFSCF) Canada $0.230B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.229B 0.00
ChromaDex (CDXC) United States $0.225B 0.00
Pfenex (PFNX) United States $0.223B 0.00
MannKind (MNKD) United States $0.217B 0.00
Kamada (KMDA) Israel $0.217B 8.28
Athersys (ATHX) United States $0.215B 0.00
Five Prime Therapeutics (FPRX) United States $0.213B 0.00
Compugen (CGEN) Israel $0.201B 0.00
CorMedix Inc (CRMD) United States $0.198B 0.00
Palatin Technologies (PTN) United States $0.197B 0.00
Sutro Biopharma (STRO) United States $0.195B 0.00
Spero Therapeutics (SPRO) United States $0.188B 0.00
Cue Biopharma (CUE) United States $0.181B 0.00
Affimed (AFMD) Germany $0.178B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.170B 0.00
Dyadic (DYAI) United States $0.168B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Cerecor (CERC) United States $0.164B 0.00
POXEL SA FRANCE (PXXLF) $0.163B 0.00
Emmaus Life Sciences (EMMA) United States $0.160B 0.00
Novavax (NVAX) United States $0.160B 0.00
Arsanis (XFOR) United States $0.159B 0.00
Acorda Therapeutics (ACOR) United States $0.155B 0.00
OSMOTICA PHARM (OSMT) United States $0.155B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.153B 0.00
BioTime (LCTX) United States $0.151B 10.10
Alcobra (ARCT) United States $0.151B 0.00
XOMA (XOMA) United States $0.150B 0.00
Enzo Biochem (ENZ) United States $0.149B 0.00
Nicox SA (NICXF) France $0.147B 0.00
Strongbridge Biopharma (SBBP) United States $0.143B 5.87
Lexicon Pharmaceuticals (LXRX) United States $0.140B 0.00
Adocia (ADOCY) France $0.140B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.137B 0.00
Mersana Therapeutics (MRSN) United States $0.130B 0.00
Windtree Therapeutics (WINT) United States $0.125B 0.00
NantKwest (NK) United States $0.125B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.121B 0.00
Celyad SA (CYAD) Belgium $0.120B 0.00
Fortress Biotech (FBIO) United States $0.120B 0.00
SESEN BIO, INC (SESN) United States $0.118B 0.00
Northwest Biotherapeutics (NWBO) United States $0.115B 0.00
TOCAGEN INC (TOCA) United States $0.113B 0.00
Synlogic (SYBX) United States $0.111B 0.00
Aduro Biotech (ADRO) United States $0.109B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.109B 0.00
Abeona Therapeutics (ABEO) United States $0.108B 0.00
Checkpoint Therapeutics (CKPT) United States $0.107B 0.00
Aptinyx (APTX) United States $0.104B 0.00
Liquidia Technologies (LQDA) United States $0.102B 0.00
Menlo Therapeutics (MNLO) United States $0.099B 0.00
OvaScience (MLND) United States $0.096B 0.00
Verastem (VSTM) United States $0.096B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.093B 0.00
Catalyst Biosciences (CBIO) United States $0.088B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.086B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.084B 0.00
Trevena (TRVN) United States $0.083B 0.00
Arbutus Biopharma (ABUS) Canada $0.083B 0.00
Selecta Biosciences (SELB) United States $0.081B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.077B 0.00
Vaccinex (VCNX) United States $0.077B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.074B 0.00
VTv Therapeutics (VTVT) United States $0.073B 0.00
Antibe Therapeutics (ATBPF) Canada $0.072B 0.00
Curis (CRIS) United States $0.070B 0.00
Orgenesis (ORGS) United States $0.070B 0.00
AquaBounty Technologies (AQB) United States $0.070B 0.00
ARAVIVE, INC (ARAV) United States $0.069B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.068B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.065B 0.00
Idera Pharmaceuticals (IDRA) United States $0.065B 0.00
Unum Therapeutics (UMRX) United States $0.063B 0.00
VBI Vaccines (VBIV) United States $0.062B 0.00
Pluristem Therapeutics (PSTI) Israel $0.060B 0.00
NewLink Genetics (NLNK) United States $0.059B 0.00
Prima BioMed (IMMP) Australia $0.057B 0.00
AIT Therapeutics (XAIR) United States $0.055B 0.00
Applied Genetic Technologies (AGTC) United States $0.054B 29.70
China Health Industries Holdings (CHHE) China $0.054B 20.47
Oncobiologics (OTLK) United States $0.054B 0.00
Ophthotech (ISEE) United States $0.046B 0.00
Clearside Biomedical (CLSD) United States $0.044B 0.00
Signal Genetics (MGEN) United States $0.044B 0.00
Vascular Biogenics (VBLT) Israel $0.042B 0.00
VIVUS (VVUS) United States $0.042B 0.00
Evogene (EVGN) Israel $0.041B 0.00
Celsion (CLSN) United States $0.041B 0.00
Apricus Biosciences (SEEL) United States $0.038B 0.00
Organovo Holdings (ONVO) United States $0.038B 0.00
Protalix BioTherapeutics (PLX) Israel $0.037B 0.00
Aptevo Therapeutics (APVO) United States $0.035B 0.00
AEterna Zentaris (AEZS) United States $0.035B 0.00
Alimera Sciences (ALIM) United States $0.035B 0.00
Celldex Therapeutics (CLDX) United States $0.035B 0.00
Proteostasis Therapeutics (PTI) United States $0.034B 0.00
BIOCARDIA INC (BCDA) United States $0.033B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.032B 0.00
Entera Bio (ENTX) Israel $0.032B 0.00
DiaMedica Therapeutics (DMAC) United States $0.032B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.027B 0.00
VistaGen Therapeutics (VTGN) United States $0.026B 0.00
Caladrius Biosciences (CLBS) United States $0.024B 0.00
Aytu Bioscience (AYTU) United States $0.023B 0.00
Soligenix (SNGX) United States $0.022B 0.00
Bionano Genomics (BNGO) United States $0.021B 0.00
Vical (VICL) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 6.33
IBio (IBIO) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
Cleveland BioLabs (CBLI) United States $0.016B 0.00
TRACON Pharmaceuticals (TCON) United States $0.016B 0.00
TrovaGene (TROV) United States $0.016B 0.00
CollPlant Holdings (CLGN) Israel $0.015B 0.00
Novogen (KZIA) Australia $0.015B 0.00
MYOS RENS Technology (MYOS) United States $0.015B 0.00
Novelion Therapeutics (NVLN) Canada $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
AmpliPhi Biosciences (ARMP) United States $0.011B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Advaxis (ADXS) United States $0.007B 0.00
Hemispherx BioPharma (HEB) United States $0.004B 0.00
Stellar Biotechnologies (EDSA) Canada $0.004B 0.00
BioPharmX (BPMX) United States $0.003B 0.00
Neuralstem (CUR) United States $0.002B 0.00